Navigation Links
Tosedostat OPAL Study Final Results Selected for Oral Presentation at the 2011 American Society of Hematology (ASH) Annual Meeting
Date:12/6/2011

SEATTLE, Dec. 7, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced that final results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia ("AML") was selected as on oral presentation at the 2011 American Society of Hematology ("ASH") Annual Meeting, which will be held on December 10-13, 2011, in San Diego, California.

Jorge Cortes, M.D., of The University of Texas MD Anderson Cancer Center, an investigator on the tosedostat study, is scheduled to present the data on Monday, December 12, 2011, during the "Acute Myeloid Leukemia - Therapy, excluding Transplantation: Clinical Studies" session that will be held from 4:30 p.m. to 6:00 p.m. Pacific time. The presentation, abstract #767, is titled, "Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia."

Additionally, results from CTI's PIX203 phase II study, in which pixantrone was substituted for doxorubicin in the CPOP-R regimen compared to the standard CHOP-R regimen in front-line aggressive non-Hodgkin's lymphoma was selected for a poster presentation.  The poster is scheduled to be presented in the "Lymphoma – Chemotherapy, excluding Pre-Clinical Models: Poster I" session on Saturday, December 10, 2011 that will be held from 5:30 to 7:30 p.m. Pacific time. The poster, abstract #1605, is titled "CPOP-R Versus CHOP-R as First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study."  

The study abstracts are available at www.hematology.org.

Investor and Analyst Meeting

Separately, CTI will host an investor and analyst meeting to present and discuss unmet medical needs in aggressive non-Hodgkin's lymphoma ("NHL"), AML and myelodysplastic s
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim®
2. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
3. New Study Shows AFECTAIR® Significantly Improved Delivery of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions
4. First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease
5. New Gene Study of ADHD Points to Defects in Brain Signaling Pathways
6. RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
7. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
8. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
9. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
10. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
11. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... with a focus on Omega-3 therapies for cardiovascular disease ... it issued 763,752 common shares of the Corporation (the ... for the period of December 5 th , 2014 ... Convertible Notes that is due on or before April ...
(Date:3/26/2015)... March 26, 2015 According to ... Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional ... Cancer, Bone Metastasis) - Global Forecasts to 2019", published ... reach around $462.0 Million growing at a CAGR of ... tables and 57 figures spread through 195 pages and ...
(Date:3/26/2015)... March 26, 2015 Zimmer Holdings, Inc. (NYSE ... ® Advanced Bearing Technology with Vitamin E by ... published earlier this month reported that, at 96 million ... Advanced Bearing Technology featuring Vitamin E grafted highly crosslinked ... wear rate reduction of 95 percent, with no cracking, ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... and the veterans returning from war, MCU, Inc launches ... educate those wanting to help our chronically ill and ... of Medical Cannabis Therapy. Using modern ... instructors gain much needed employment utilizing the internet to ...
... WARRENDALE, Pa., Sept. 17 At MEDRAD, Inc., ... year marks MEDRAD,s 11th annual Day of Caring, ... opportunity to spend a workday volunteering in their ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO) Over 1000 MEDRAD employees ...
Cached Medicine Technology:Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill 2MEDRAD Employees Demonstrate Longstanding Commitment to Community 2MEDRAD Employees Demonstrate Longstanding Commitment to Community 3
(Date:3/27/2015)... Smile Brands Inc. ( http://www.smilebrands.com ), one ... to dental groups in the United States, is announcing ... office in Hendersonville, TN. , Located at ... Castle Dental office provides families with a convenient, comfortable ... quality dental care. Hendersonville marks the eleventh Castle Dental ...
(Date:3/27/2015)... Hawkins, Pastor and Overseer at The House of Yahweh in ... is through the Laws of Peace written in the Holy ... article titled, “Yahweh’s Way-The Great Difference” focuses on the past ... the original biblical instructions has caused mass chaos worldwide. ... in the world is based on man-made laws that will ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... a Quaker-based, philanthropic, grant-making foundation committed to raising ... behavioral healthcare is delivered. , The Scattergood Foundation ... advance Behavioral Health Policy and Practice through the ... SoundsLikeIBS Program App is designed to guide ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Let’s not ... store. Fresh produce are today’s traffic magnets. Three out ... supermarket because of their produce department, according to a ... ever as people are looking to add more fruits ... Your Produce Manager® Day is April 2. As featured ...
(Date:3/26/2015)... Franklin, TN (PRWEB) March 26, 2015 ... http://www.healthclick.com . This website is dedicated to providing information ... therapy and occupation therapy community. As a leader ... North American Seminars provided over 200 live and online ... PT OT continuing Education Courses :, A Master Clinicians ...
Breaking Medicine News(10 mins):Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3
... many different accounts of the crucifixion of Jesus find ... antique sources generally lack descriptions of crucifixions, says Gunnar ... doctoral thesis on the topic. Encyclopaedias, monographs and ... Jesus had to endure on Golgotha in Jerusalem. There ...
... ... research.,Updated website shows, based on research, reasons for RSI and Carpal Tunnel Syndrome and how ... ... the patented, ergonomic HandShoe Mouse, have decided to give complete access to its ergonomic fundamental ...
... ... with Pilot Pen to create a line of new products showing support ... a nonprofit committed to providing direct financial assistance to uninsured and underserved ... of breast cancer. To show support Pilot Pen is launching 10 new ...
... discussing anomalies found in ,routine, MRIs, researchers say , ... anomalies are often detected in children who undergo "routine" ... help pediatricians handle these findings, a new study suggests. ... they want to share with parents about such findings ...
... ... Marketing, Inc. ( www.hivemindinc.com ), a new marketing “mashup” that integrates ... media marketing, announced today that the firm has been selected as ... in high-performance BioAnalytical instruments, software, and assays for basic biology and ...
... In the ... of cycling injuries and urges caution on the roads , ... (PRWEB) June 14, 2010 -- National Accident Helpline is urging cyclists and other ... an increasing number of people take to their bikes, often for the first time in months., ...
Cached Medicine News:Health News:What do we really know about the crucifixion of Jesus? 2Health News:Ergonomic HandShoe Mouse Publish Proof of Unique Difference with Competition 2Health News:Ergonomic HandShoe Mouse Publish Proof of Unique Difference with Competition 3Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 2Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 3Health News:Harmless Brain Abnormalities in Kids Pose Disclosure Dilemmas 2Health News:Molecular Devices Relaunches with HiveMind Marketing 2Health News:Molecular Devices Relaunches with HiveMind Marketing 3Health News:Molecular Devices Relaunches with HiveMind Marketing 4Health News:Break The Injury Cycle, Says National Accident Helpline 2
... The UVS800DDA Universal Vacuum Source is a ... Cold Trap and 4-headed, Oil-free Vacuum Pump. It ... chemistry use and abuse., Combines a ... single housing eliminating extra tubing connections. ...
... designed for a wide variety of laboratory applications. ... eliminates oil mist vapors because it doesn't consume ... less fuss., Quiet, efficient operation ... ETFE and PFA heads , Recommended ...
... several different two-stage, oil-sealed, rotary vane vacuum ... applications. Each pump comes complete with a ... and Oil Mist Filter (EMF-10). The GBORK ... ballast to keep the oil clean without ...
Produces vacuum pressures required for 96 well kits...
Medicine Products: